Teresa Morato-Mantilla
Prosperidad, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
LDL as a therapeutic objective.
Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: October 07, 2019
LDL as a therapeutic target.
Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: August 09, 2019
Management of atherogenic dyslipidemia in the primary care setting in Spain.
Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: July 26, 2018
The role of atherogenic dyslipidaemia in clinical practice guidelines
Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: November 26, 2015
To improve cardiovascular health: we are forced for not loosing impulse
Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: October 01, 2015
METABOLIC SYNDROME IN PATIENTS WITH CLINICAL PHENOTYPE "HYPERTRIGLYCERIDEMIC WAIST"
Journal: Nutricion hospitalaria
Published: August 31, 2015
Cardiometabolic Risk Related to the Association of hypertriglyceridemia-Low HDLc.
Journal: Current pharmaceutical design
Published: August 01, 2015
Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology Position Statement on Dyslipidemia Management: differences between the European and American Guidelines.
Journal: Revista espanola de salud publica
Published: May 07, 2015
Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines
Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: September 11, 2014
Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology Position Statement on Dyslipidemia Management. Differences Between the European and American Guidelines
Journal: Hipertension y riesgo vascular
Published: September 07, 2014
Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain
Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: June 25, 2014
Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines.
Journal: Revista espanola de cardiologia (English ed.)
Published: April 24, 2014
Last Updated: 09/26/2026